Streptococcus Pneumoniae

Infectious Diseases
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
Blood cultureN/A1 trial
Active Trials
NCT01308827Suspended4,000Est. Mar 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerBlood culture

Clinical Trials (1)

Total enrollment: 4,000 patients across 1 trials

NCT01308827PfizerBlood culture

Costa Rica Epidemiological Study on S. Pneumoniae

Start: Mar 2011Est. completion: Mar 20144,000 patients
N/ASuspended

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space